CORT - Corcept Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CORT is currently covered by 4 analysts with an average price target of $92.95. This is a potential upside of $18.99 (25.68%) from yesterday's end of day stock price of $73.96.

Corcept Therapeutics's activity chart (see below) currently has 99 price targets and 80 ratings on display. The stock rating distribution of CORT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90.61% with an average time for these price targets to be met of 259.18 days.

Highest price target for CORT is $145, Lowest price target is $131, average price target is $138.67.

Most recent stock forecast was given by EDWARD NASH from CANACCORD on 24-Sep-2025. First documented stock forecast 11-Oct-2015.

Currently out of the existing stock ratings of CORT, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$140

$51.85 (58.82%)

$140

16 days ago
(24-Sep-2025)

7/11 (63.64%)

$57.27 (69.23%)

325

Buy

$145

$56.85 (64.49%)

$150

5 months 5 days ago
(05-May-2025)

15/19 (78.95%)

$74.26 (104.98%)

134

Buy

$131

$42.85 (48.61%)

$78

6 months 8 days ago
(02-Apr-2025)

7/8 (87.5%)

$51.63 (65.05%)

86

Buy

$38

$13.94 (57.94%)

$29

1 years 11 months 5 days ago
(06-Nov-2023)

2/3 (66.67%)

$12.09 (46.66%)

37

Hold

$29

$-59.15 (-67.10%)

$26

2 years 2 months 8 days ago
(02-Aug-2023)

4/4 (100%)

$-2.24 (-7.17%)

262

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CORT (Corcept Therapeutics) average time for price targets to be met?

On average it took 259.18 days on average for the stock forecasts to be realized with a an average price target met ratio 90.61

Which analyst has the current highest performing score on CORT (Corcept Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the most public recommendations on CORT (Corcept Therapeutics)?

Edward Nash works at CANACCORD and has 5 price targets and 5 ratings on CORT

Which analyst is the currently most bullish on CORT (Corcept Therapeutics)?

Swayampakula Ramakanth with highest potential upside - $56.85

Which analyst is the currently most reserved on CORT (Corcept Therapeutics)?

David Buck with lowest potential downside - -$77.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?